Ana León

Level of <i>HER2</i> Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

Carlos Gómez-Martín, Roberto Pazo-Cid, Antonieta Salud et al. · Journal of Clinical Oncology · 2013 · 196 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab

Asunción Díaz-Serrano, Bárbara Angulo, Carolina Domínguez et al. · The Oncologist · 2018 · 58 citations · Full text

Medicine, Molecular Medicine, Oncology +17

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer

Cristina Caramés, Ion Cristóbal, Víctor Moreno et al. · International Journal of Colorectal Disease · 2015 · 47 citations

Medicine, Oncology, Surgery +14

A Phase II Study of Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

Laura García‐Estévez, Norberto Batista, Pedro Sánchez‐Rovira et al. · Clinical Breast Cancer · 2008 · 35 citations

Medicine, Oncology, Pharmacology +14

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer

Cristina Caramés, Ion Cristóbal, Víctor Moreno et al. · International Journal of Molecular Sciences · 2016 · 31 citations · Full text

Medicine, Oncology, Surgery +17